Hospital or health organisation · founded 1859
Providence Health & Services
Renton, United States · providence.org
- Citations, last 5 years
- 2 040
- Works, last 5 years
- 220
- h-index
- 95
- Scientists listed
- 19
- Grants since 2016
- 10
Grants received
2025–2030 · research · R01
Enhancing the efficacy of radiation by spatially restricting anti-TGFb treatment to the tumor
Kristina H Young · Providence Health & Services · funded by National Institutes of Health
2024–2026 · research · R03
Develop a PET radiotracer suitable for in vivo imaging of TGFβ
Kristina H Young · Providence Health & Services · funded by National Institutes of Health
2023–2024 · research · R21
DNASE1L3 regulation of anti-tumor immune responses following radiation therapy
Michael James Gough · Providence Health & Services · funded by National Institutes of Health
2023–2024 · research · R21
DNASE1L3 regulation of anti-tumor immune responses following radiation therapy
Michael James Gough · Providence Health & Services · funded by National Institutes of Health
2023–2025 · research · R03
Assessing the impact of financial incentives on provision of interpretive services in Medicaid
Monique Gill · Providence Health & Services · funded by Agency for Healthcare Research and Quality
2022–2025 · career development · K22
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS
Jianguo Huang · Providence Health & Services · funded by National Institutes of Health
2022–2025 · career development · K22
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS
Jianguo Huang · Providence Health & Services · funded by National Institutes of Health
2022–2025 · career development · K22
DISSECTING THE ROLES OF FAT1 AND NEAT1 IN SOFT TISSUE SARCOMA DEVELOPMENT AND METASTASIS USING NOVEL IN VIVO SARCOMA MODELS
Jianguo Huang · Providence Health & Services · funded by National Institutes of Health
2020–2027 · research · R37
Targeting Rheostatic Mechanisms in Melanoma
Allie H. Grossmann · Providence Health & Services · funded by National Institutes of Health
2016–2018 · award
STINGRay therapy combines innate and adaptive immunity to control tumors
Jason Baird · Providence Health & Services · funded by American Cancer Society